Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · IEX Real-Time Price · USD
29.81
-1.82 (-5.75%)
Apr 19, 2024, 11:21 AM EDT - Market open
IART Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for IART stock have an average target of 45, with a low estimate of 37 and a high estimate of 53. The average target predicts an increase of 50.96% from the current stock price of 29.81.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IART stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 3 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Total | 8 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Sell → Hold Upgrades $38 | Strong Sell → Hold | Upgrades | $38 | +27.47% | Apr 3, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $46 → $41 | Hold | Maintains | $46 → $41 | +37.54% | Mar 1, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $55 → $49 | Buy | Maintains | $55 → $49 | +64.37% | Feb 29, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $44 → $46 | Hold | Maintains | $44 → $46 | +54.31% | Dec 22, 2023 |
| Truist Securities | Truist Securities | Hold Maintains $39 → $44 | Hold | Maintains | $39 → $44 | +47.60% | Dec 14, 2023 |
Financial Forecast
Revenue This Year
1.65B
from 1.54B
Increased by 6.97%
Revenue Next Year
1.75B
from 1.65B
Increased by 5.82%
EPS This Year
3.26
from 0.84
Increased by 287.68%
EPS Next Year
3.69
from 3.26
Increased by 13.33%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.8B | 1.9B | 2.0B | 2.0B |
| Avg | 1.6B | 1.7B | 1.9B | 2.0B |
| Low | 1.6B | 1.6B | 1.7B | 1.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 13.5% | 16.9% | 15.4% | 10.2% |
| Avg | 7.0% | 5.8% | 6.2% | 7.1% |
| Low | 1.9% | -0.5% | -1.8% | 2.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 3.37 | 3.92 | 4.62 | 5.34 |
| Avg | 3.26 | 3.69 | 4.08 | 5.19 |
| Low | 3.10 | 3.41 | 3.74 | 4.99 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 301.3% | 20.3% | 25.2% | 30.9% |
| Avg | 287.7% | 13.3% | 10.7% | 27.1% |
| Low | 268.6% | 4.7% | 1.4% | 22.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.